Home > Products > CD19 & CD28
> Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (IgG-scFv)
Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (IgG-scFv) (CAT#: IGFV-040)
Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (IgG-scFv) (IGFV-040). Click the button below to contact us or submit your feedback about this product.